Director Eitan Yaron buys 100,000 shares of MRAI at $1.00; stock down -27.4% from 52-week high amid -24.2% annual revenue decline.
Director Eitan Yaron purchased 100,000 shares at $1.00 on 2025-11-07, increasing his holdings by 10.1% to 1,089,073 shares post-transaction. The purchase occurs against a deteriorating stock backdrop: MRAI is trading -27.4% from its 52-week high and -9.8% over the last 30 days, while fundamentals show annual revenue declining -24.2% and the company posting a full-year net loss of $-3,494,000.00. His prior five buys at MRAI show mixed timing: two achieved positive 90-day returns (including a +122.8% gain following a January 2024 purchase), but three resulted in 90-day losses of -20.4%, -24.8%, and -46.7%, suggesting inconsistent execution. The filing also reflects a cluster pattern with 2 other insiders buying within the past 14 days, which may indicate coordinated confidence or response to external circumstances rather than isolated conviction.